Thursday, 20 February 2020

Japan News

  • Millennium starts ph III trial for multiple myeloma drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating MLN9708 in patients with relapsed or refractory multiple myeloma. The ...Read more

  • Astellas looks to sell dermatology assets: Sources

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth between $500 million and $1 billion, according to the sources. Astellas...Read more

  • SymBio Pharma completes patient enrollment

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial of Treakisym (bendamustine hydrochloride, SyB L-0501) in frontline low...Read more

  • OMRON reports performance for Q1 2012

    Japan |  Company results | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    Singapore: OMRON Corporation reported consolidated performance for the first quarter (Q1) of fiscal 2012, which included the three months from April 1-to-June 30, 2012. Omron group's net sa...Read more

  • International consortium sequences tomato genome

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the genomes of the domesticated tomato and its wild ancestor, Solanum pimp...Read more

  • Japan approves world's first transdermal ß1-blocker patch

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

    Singapore: Japan-based Nitto Denko announced that Toa Eiyo has received manufacturing and marketing authorization in Japan from the Japanese Ministry of Health, Labour and Welfare for "Biso...Read more

  • Eisai, Toyama get marketing approval for iguratimod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to market iguratimod for the treatment of rheumatoid arthritis. Iguratimod, ...Read more

  • Daiichi to launch Inavir anti-influenza product in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Nov, 2012

    Singapore: Daiichi Sankyo submitted an application for a partial label change in Japan to manufacture and market the influenza anti-viral product Inavir Dry Powder Inhaler (laninamivir octa...Read more

  • FDA slams Shionogi for eyeing profit over patient safety

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

    Singapore: The FDA had during September 2012 informed Shionogi that it need to conduct two clinical trials in order to evaluate the risk of irregular heartbeat associated with its Rybix pai...Read more

  • Medical laser market to reach $8.8 bn by 2018: GIA

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, leading to significant rise in the number of procedures carried out u...Read more

  • Chugai, Nippon Shinyaku tie up for drug development

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co-develop and co-market GA101 (obinutuzumab), the first glycoengineere...Read more

  • INC Research opens two new offices in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, announced the establishment of INC ...Read more

  • Deregulation will boost Japanese pharma sector

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent of the world market. The industry grew from $62.8 billion in 2005 to i...Read more

  • Takeda gets FDA nod for three diabetes drugs

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: Japan-headquartered Takeda Pharmaceutical received the US Food and Drug Administration (FDA) approval for Nesina (alogliptin) and the fixed-dose combination (FDC) therapies Oseni...Read more

  • Teva appoints new chairman for Japan, South Korea

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Teva Pharmaceutical has appointed Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head of Business Development Asia-Pacific. Currently serving as exec...Read more

  • Germany seeks closer partnership with Japan in biopharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: Germany Trade & Invest and the Health-Made in Germany initiative will join forces at this year's BioJapan 2012 from October 10-12. Representatives from German and Japanese bi...Read more

  • Interphex Japan: Japan pharma eyes China, India

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, kick started with much pomp and grandeur. The keynote address, which f...Read more

  • Daiichi may take legal action against ex-Ranbaxy promoters

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2013

    Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of the US Food and Drug Administration (FDA) felony charges over drug...Read more